NASDAQ:VCSA - Nasdaq - US91854V2060 - Common Stock - Currency: USD
If you're falling behind on your retirement savings, take heart — you're not alone. Here's a look at five clever ways to speed up your retirement savings.
Fred Alger Management, an investment management company, released its “Alger Small Cap Focus Fund” first quarter 2025 investor letter. A copy of the letter can be downloaded here. Changing trade, monetary, and fiscal policies increased volatility in US stocks. The emergence of artificial intelligence (AI) models from China added to the uncertainty. Against this backdrop, […]
Vacasa stock is trading higher on Monday after the company announced that it and Casago have agreed to merge.
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Vacasa (NASDAQ:VCSA) just reported results for the second quarter of 2024.Vacas...
Vacasa (VCSA) announced that the Special Committee of its Board of Directors has unanimously determined that the revised unsolicited acquisition proposal from Davidson Kempner Capital Management LP does not constitute, and is not reasonably likely to result in, a “superior proposal” pursuant to the terms of the definitive merger agreement between Casago and Vacasa. “In making its determination, the Special Committee considered a number of factors, including: that the Proposal remains conditioned
VCSA stock results show that Vacasa beat analyst estimates for earnings per share but missed on revenue for the second quarter of 2024.
With Davidson Kempner's latest bid for Vacasa at $5.83 per share and the Vacasa board-endorsed bid from Casago at $5.30 per share, one thing is certain — this is not the end of the story.
Newsmax stock soared 180% Tuesday, extending its massive 735% gain on Monday following the conservative cable news outlet’s IPO.
Shares of Hims & Hers Health (NYSE: HIMS) surged on Tuesday, closing the session up 5.25% after having been up by as much as 14% earlier. The day's gain was powered by the telehealth company's announcement of plans to sell the blockbuster weight loss drug Zepbound on its platform. Hims & Hers revealed Tuesday that it will begin offering branded versions of Eli Lilly's tirzepatide -- the active ingredient in weight loss drug Zepbound and diabetes medicine Mounjaro.
/PRNewswire/ -- Universal Technical Institute, Inc. (NYSE: UTI), a leading workforce education provider for transportation, skilled technicians, energy and...
Mentions: UTI
/PRNewswire/ -- The following statement is being issued by Levi & Korsinsky, LLP: To: All Persons or Entities who own Vacasa Inc ("VCSA" or the "Company")...
/PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws...
Mentions: JWN
Mentions: CTV